| Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action MA Garcia, J Gil, I Ventoso, S Guerra, E Domingo, C Rivas, M Esteban Microbiology and Molecular Biology Reviews 70 (4), 1032-1060, 2006 | 1025 | 2006 |
| The dsRNA protein kinase PKR: virus and cell control MA Garcia, EF Meurs, M Esteban Biochimie 89 (6-7), 799-811, 2007 | 778 | 2007 |
| TRAF family proteins link PKR with NF-κB activation J Gil, MA García, P Gomez-Puertas, S Guerra, J Rullas, H Nakano, ... Molecular and cellular biology 24 (10), 4502-4512, 2004 | 189 | 2004 |
| Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells C Morata-Tarifa, G Jiménez, MA García, JM Entrena, C Griñán-Lisón, ... Scientific reports 6 (1), 18772, 2016 | 120 | 2016 |
| The impact of PKR activation: from neurodegeneration to cancer JA Marchal, GJ Lopez, M Peran, A Comino, JR Delgado, ... The FASEB Journal 28 (5), 1965-1974, 2014 | 120 | 2014 |
| The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-κB activation J Gil, J Rullas, MA García, J Alcamí, M Esteban Oncogene 20 (3), 385-394, 2001 | 105 | 2001 |
| Functionalized nanostructures with application in regenerative medicine M Perán, MA García, E López-Ruiz, M Bustamante, G Jiménez, ... International journal of molecular sciences 13 (3), 3847-3886, 2012 | 98 | 2012 |
| Selección de Personal-Sistema Integrado M García, E Hierro, J Jiménez Madrid. Editorial ESIC, 2001 | 96 | 2001 |
| Resistance to viral infection of super p53 mice C Munoz-Fontela, M Angel Garcia, I Garcia-Cao, M Collado, J Arroyo, ... Oncogene 24 (18), 3059-3062, 2005 | 93 | 2005 |
| The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation M Esteban, MA Garcia, E Domingo-Gil, J Arroyo, C Nombela, C Rivas Journal of General Virology 84 (6), 1463-1470, 2003 | 90 | 2003 |
| EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer MJ Serrano, FG Ortega, MJ Alvarez-Cubero, R Nadal, P Sanchez-Rovira, ... Oncotarget 5 (17), 7486, 2014 | 89 | 2014 |
| Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance J Gil, MA Garcı́a, M Esteban FEBS letters 529 (2-3), 249-255, 2002 | 84 | 2002 |
| Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L MA García, S Guerra, J Gil, V Jimenez, M Esteban Oncogene 21 (55), 8379-8387, 2002 | 79 | 2002 |
| How can nanotechnology help to repair the body? Advances in cardiac, skin, bone, cartilage and nerve tissue regeneration M Perán, MA García, E Lopez-Ruiz, G Jiménez, JA Marchal Materials 6 (4), 1333-1359, 2013 | 78 | 2013 |
| The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells MA García, E Carrasco, M Aguilera, P Alvarez, C Rivas, JM Campos, ... PLoS One 6 (8), e23887, 2011 | 74 | 2011 |
| SIRT1 stabilizes PML promoting its sumoylation M Campagna, D Herranz, MA Garcia, L Marcos-Villar, ... Cell Death & Differentiation 18 (1), 72-79, 2011 | 70 | 2011 |
| Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil Y Asara, JA Marchal, E Carrasco, H Boulaiz, G Solinas, P Bandiera, ... International journal of molecular sciences 14 (8), 16600-16616, 2013 | 68 | 2013 |
| Antiviral action of the tumor suppressor ARF MA García, M Collado, C Muñoz‐Fontela, A Matheu, L Marcos‐Villar, ... The EMBO Journal 25 (18), 4284-4292, 2006 | 63 | 2006 |
| Activating transcription factor 4 modulates TGFβ-induced aggressiveness in triple-negative breast cancer via SMAD2/3/4 and mTORC2 signaling A González-González, E Muñoz-Muela, JA Marchal, FE Cara, MP Molina, ... Clinical Cancer Research 24 (22), 5697-5709, 2018 | 54 | 2018 |
| 5-Fluorouracil derivatives: a patent review (2012–2014) E Carrillo, SA Navarro, A Ramírez, MÁ García, C Griñán-Lisón, M Perán, ... Expert opinion on therapeutic patents 25 (10), 1131-1144, 2015 | 52 | 2015 |
